A retrospective study of the efficacy of intense pulsed light delivered by the Lacrystim® for meibomian gland dysfunction therapy

BACKGROUND: Meibomian gland dysfunction is the most common etiology of dry eye disease worldwide and intense pulsed light appears to be a promising treatment with encouraging results. Lacrystim® is a new IPL device (CE marking in 2019) and no studies have yet been published on it. We propose the fir...

Descripción completa

Detalles Bibliográficos
Autores principales: Trone, Marie-Caroline, Garcin, Thibaud, Ollier, Edouard, Thuret, Gilles, Gain, Philippe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9356507/
https://www.ncbi.nlm.nih.gov/pubmed/35933379
http://dx.doi.org/10.1186/s12886-022-02531-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9356507/
https://www.ncbi.nlm.nih.gov/pubmed/35933379
http://dx.doi.org/10.1186/s12886-022-02531-7

Ejemplares similares